THANK YOU to our study participants, study partners, and researchers that contributed to this FDA drug approval. We're proud to have been a top enrolling site in the pivotal Kisunla trials, with and to have passed a two-week on-site FDA audit of our work with no findings. We're continuing to enroll study participants in the search for more effective and safe treatments being evaluated for the prevention and treatment of Alzheimer's. In particular, we're now expanding our reach in diverse communities that have been underrepresented across Alzheimer's research.
关于我们
Irvine Clinical Research is an independent, physician investigator-owned clinic specializing in Phase 2-3 sponsored clinical trials in neurology and psychiatry. We have a demonstrated history of enrolling subjects quickly, producing quality data to Sponsors, and ensuring the highest standard of patient care. Our largest areas of study are in Mild Cognitive Impairment/Early Alzheimer's Disease and Depression therapeutic trials. According to publicly available CMS data, Irvine Clinical Research is the top independent site in Alzheimer’s Disease clinical trials in the state of California, as measured by industry research grants.
- 网站
-
https://irvineclinical.com/
Irvine Clinical Research的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Irvine，CA
- 类型
- 私人持股
- 创立
- 1978
- 领域
- Clinical Research、Clinical Trials、Medical、Neuropsychiatry、Neurology、Psychiatry和Alzheimer's Disease
地点
-
主要
获取路线
2515 McCabe Way
Suite 350
US，CA，Irvine，92614